株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

不妊治療関連機器の世界市場の予測 〜2023年:製品別 (医療機器、メディア、付属品)・処置別 (生殖補助医療(ART:体外受精(IVF)・顕微授精 (ICSI)・代理出産)、人工授精、腹腔鏡手術、卵管結紮)・患者の種類別 (女性/男性)・エンドユーザー別

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User - Forecasts to 2023

発行 MarketsandMarkets 商品コード 341215
出版日 ページ情報 英文 177 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.66円で換算しております。
Back to Top
不妊治療関連機器の世界市場の予測 〜2023年:製品別 (医療機器、メディア、付属品)・処置別 (生殖補助医療(ART:体外受精(IVF)・顕微授精 (ICSI)・代理出産)、人工授精、腹腔鏡手術、卵管結紮)・患者の種類別 (女性/男性)・エンドユーザー別 Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User - Forecasts to 2023
出版日: 2018年11月06日 ページ情報: 英文 177 Pages
概要

世界の不妊治療の市場規模は、2018年には15億米ドル、2023年には22億米ドルと、8.0%のCAGR (複合年間成長率) で成長する、と見られています。妊娠率が低下したことや、各種の不妊治療オプションの知名度が上昇したことが、市場成長の一因となっています。他方、治療コストの高さや、政府の厳格な規制などが、市場成長の主な抑制要因となっています。

当レポートでは、不妊治療の世界市場について調査し、市場の発展動向、市場成長への各種影響因子の分析、製品・処置・患者の種類・エンドユーザー・地域別の動向、市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

FIGURE 11 INFERTILITY TREATMENT MARKET

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • 妊娠率の低下
      • 世界各国での不妊症クリニックの増加
      • 技術進歩:不妊治療機器の進歩、タイムラプス技術の利用増加
      • PPP (官民連携) 方式での投資・融資・資金援助の増加
    • 抑制要因
      • 先進国での生殖補助医療の処置コストの高さ
      • 業界に不都合な政府の規制
    • 市場機会
      • 新興国市場での成長機会
        • 医療インフラの改善
        • (治療費の低さを生かした) メディカルツーリズムの発展
      • 一人親世帯・同性婚世帯での不妊治療オプションの利用
    • 課題
      • ART処置に関する不安感
      • 中高年女性の場合の有効性低下

第6章 不妊治療市場:製品別

  • イントロダクション
  • 医療機器
    • 顕微鏡
    • 画像システム
    • 精子分析システム
    • 卵子吸引ポンプ
    • マイクロマニュピレーターシステム
    • インキュベーター
    • ガス分析器
    • レーザーシステム
    • 液体窒素保存容器
  • メディア・消耗品
  • 付属品

第7章 不妊治療市場:処置別

  • イントロダクション
  • 生殖補助医療(ART)
    • 体外受精(IVF)
      • IMSI (精子選別式IPSI)
      • 配偶子提供
    • IPSI (顕微授精)
    • 代理出産
  • 人工授精
    • 子宮内人工授精
    • 子宮頚部内人工授精
    • 管内授精
  • 不妊症手術
    • 腹腔鏡手術
    • 子宮鏡手術
    • 筋腫摘出手術
    • 開腹手術
    • 卵管結紮反転
    • 精索静脈瘤切除術
      • 精管吻合
      • 精管副睾丸吻合術
  • その他の処置

第8章 不妊治療市場:患者の種類別

  • イントロダクション
  • 女性向け不妊治療
  • 男性向け不妊治療

第9章 不妊治療市場:エンドユーザー別

  • イントロダクション
  • 生殖医療センター
  • 病院・診療所
  • 研究機関
  • 精子バンク

第10章 不妊治療市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランスなど)
  • アジア太平洋地域 (日本、中国、インドなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第11章 競合環境

  • 概要
  • 不妊治療:市場シェア分析
  • 競合シナリオ

第12章 企業プロファイル (事業概要、主要製品、近年の動向、SWOT分析、MnMの見解)

  • COOK GROUP INCORPORATED
  • ESCO MICRO PTE. LTD.
  • GENEA LIMITED
  • HAMILTON THRONE, LTD.
  • IHMEDICAL A/S
  • IRVINE SCIENTIFIC (JXホールディングス・グループの一員)
  • IVFTECH APS
  • 北里コーポレーション
  • MEDGYN PRODUCTS, INC.
  • ROCKET MEDICAL PLC
  • SOMATEX MEDICAL TECHNOLOGIES GMBH
  • THE BAKER COMPANY, INC.
  • THE COOPER COMPANIES, INC.
  • THERMO FISHER SCIENTIFIC
  • VITROLIFE AB
  • ZEISS GROUP

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 2: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 3: INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: IMAGING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: SPERM ANALYZER SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: OVUM ASPIRATION PUMPS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: MICROMANIPULATOR SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: GAS ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: LASER SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: CRYOSYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: MEDIA & CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: ACCESSORIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 16: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 17: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: IN VITRO FERTILIZATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: SURROGACY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 22: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: FERTILITY SURGERY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 24: FERTILITY SURGERY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 27: FEMALE INFERTILITY TREATMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: MALE INFERTILITY TREATMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 30: INFERTILITY TREATMENT MARKET FOR FERTILITY CLINICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: INFERTILITY TREATMENT DEVICES MARKET FOR HOSPITALS AND SURGICAL CLINICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: INFERTILITY TREATMENT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 38: NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 40: US: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 41: US: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 42: US: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 43: US: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 44: CANADA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 45: CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 46: CANADA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 48: EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 50: EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 51: EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 52: EUROPE: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 53: GERMANY: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 54: GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 55: GERMANY: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: GERMANY: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: UK: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 58: UK: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 59: UK: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: UK: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 61: FRANCE: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 62: FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 63: FRANCE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 64: FRANCE: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 65: ROE: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 66: ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 67: ROE: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 68: ROE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: APAC: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 70: APAC: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 71: APAC: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 72: APAC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: APAC: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 74: JAPAN: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 75: JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 76: JAPAN: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: JAPAN: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 78: CHINA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 79: CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 80: CHINA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: CHINA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 82: INDIA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 83: INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 84: INDIA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: INDIA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 86: ROAPAC: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 87: ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 88: ROAPAC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: ROAPAC: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 90: ROW: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 91: ROW: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 92: ROW: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 93: ROW: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: ROW: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 95: LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 96: LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 97: LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 99: MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)
  • TABLE 100: MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 101: MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 103: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 104: EXPANSIONS
  • TABLE 105: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
  • TABLE 106: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: INFERTILITY TREATMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
  • FIGURE 4: TOP-DOWN APPROACH MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: INFERTILITY TREATMENT MARKET SHARE, BY PRODUCT, 2018
  • FIGURE 8: INFERTILITY TREATMENT MARKET SHARE, BY PATIENT TYPE, 2018
  • FIGURE 9: INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE INFERTILITY TREATMENT MARKET
  • FIGURE 11: DECLINING GLOBAL FERTILITY RATE-MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 12: MEDIA & CONSUMABLES MARKET IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: ASSISTED REPRODUCTIVE TECHNOLOGY SEGMENT TO DOMINATE THE ASIA PACIFIC INFERTILITY TREATMENT MARKET IN 2018
  • FIGURE 14: FEMALE INFERTILITY TREATMENT SEGMENT WILL CONTINUE TO DOMINATE THE INFERTILITY TREATMENT MARKET IN 2023
  • FIGURE 15: FERTILITY CENTERS TO DOMINATE THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 17: INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: DECLINING GLOBAL FERTILITY RATE (1960-2016)
  • FIGURE 19: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 20: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2018 VS 2023 (USD MILLION)
  • FIGURE 21: FEMALE INFERTILITY TREATMENT SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 23: INFERTILITY TREATMENT MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 24: NORTH AMERICA: INFERTILITY TREATMENT MARKET SNAPSHOT
  • FIGURE 25: EUROPE: INFERTILITY TREATMENT MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: INFERTILITY TREATMENT MARKET SNAPSHOT
  • FIGURE 27: THE COOPER COMPANIES HELD THE LEADING POSITION IN THE INFERTILITY TREATMENT MARKET, 2017
  • FIGURE 28: HAMILTON THRONE LTD.: COMPANY SNAPSHOT
  • FIGURE 29: THE COOPER COMPANIES: COMPANY SNAPSHOT
  • FIGURE 30: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 31: VITROLIFE: COMPANY SNAPSHOT
  • FIGURE 32: ZEISS GROUP: COMPANY SNAPSHOT
目次
Product Code: MD 3765

"The infertility treatment market is projected to grow at a CAGR of 8.0% during the forecast period."

The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%. Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and rising public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

"The female infertility treatment segment is expected to hold the largest market share during the forecast period."

On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

"The fertility centers segment is expected to grow at the highest rate during the forecast period."

On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.

"The European infertility treatment market is expected to hold the second-largest share during the forecast period."

Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments. Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 25%, Tier 2 - 30%, and Tier 3 - 45%
  • By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
  • By Region: North America - 35%, Europe - 26%, APAC - 23%, and RoW - 16%

The major players in the market include: The Cooper Companies Inc. (US), Cook Group Incorporated (US), and Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SOMATEX Medical Technologies GmbH (Germany).

Research Coverage:

This report studies the infertility treatment market based on product, procedure, patient type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infertility treatment market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
    • 2.1.3. MARKET SIZE ESTIMATION
      • 2.1.3.1. Product-based Market Estimation
    • 2.1.4. PRIMARY RESEARCH VALIDATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. LIMITATIONS
    • 2.2.2. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INFERTILITY TREATMENT: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: INFERTILITY TREATMENT MARKET, BY PRODUCT
  • 4.3. ASIA PACIFIC: INFERTILITY TREATMENT MARKET SHARE, BY PROCEDURE(2018)
  • 4.4. INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2018 VS. 2023(USD MILLION)
  • 4.5. INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023(USD MILLION)
  • 4.6. GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Declining fertility rate
      • 5.2.1.2. Rising number of fertility clinics worldwide
      • 5.2.1.3. Technological advancements
        • 5.2.1.3.1. Advancements in infertility treatment devices
        • 5.2.1.3.1. Increase in the use of time-lapse technology
      • 5.2.1.4. Increasing public-private investments, funds, and grants
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High procedural cost of assisted reproductive techniques in developed markets
      • 5.2.2.2. Unsupportive government regulations
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth opportunities in emerging markets
        • 5.2.3.1.1. Improving healthcare infrastructure
        • 5.2.3.1.2. Increasing medical tourism due to low treatment costs
      • 5.2.3.2. Use of fertility treatment options by single parents and same-sex couples
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Concerns related to ART procedures
      • 5.2.4.2. Reduced efficacy among older women

6. INFERTILITY TREATMENT MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. EQUIPMENT
    • 6.2.1. MICROSCOPES
      • 6.2.1.1. Growing technological advancements in the field of microscopy resulting in the growing adoption of microscopes
    • 6.2.2. IMAGING SYSTEMS
      • 6.2.2.1. Emergence of time-lapse imaging systems driving the growth of the infertility treatment imaging systems market
    • 6.2.3. SPERM ANALYZER SYSTEMS
      • 6.2.3.1. Automated sperm analyzer systems permitting internal and external quality control and better reproducibility
    • 6.2.4. OVUM ASPIRATION PUMPS
      • 6.2.4.1. Ovum aspiration pumps enable smooth collection of oocytes during infertility treatment procedures
    • 6.2.5. MICROMANIPULATOR SYSTEMS
      • 6.2.5.1. Micromanipulators are commonly used for the treatment of male infertility, particularly cases pertaining to poor sperm quantity/mobility
    • 6.2.6. INCUBATORS
      • 6.2.6.1. Incubators play a vital role in embryo development and improved clinical outcomes
    • 6.2.7. GAS ANALYZERS
      • 6.2.7.1. Gas analyzers contain multiple ports enabling analysis of sequential gas samples
    • 6.2.8. LASER SYSTEMS
      • 6.2.8.1. The common applications of laser systems include treament of stress urinary incontinence and vaginal tightening
    • 6.2.9. CRYOSYSTEMS
      • 6.2.9.1. Demand for cryosystems is on the rise as women are seeking to extend their childbearing years
  • 6.3. MEDIA & CONSUMABLES
    • 6.3.1. EASY AVAILABILITY OF CULTURE MEDIA COUPLED WITH THE GROWING AWARENESS AMONG INDIVIDUALS DRIVING THE GROWTH OF THE MEDIA & CONSUMABLES SEGMENT
  • 6.4. ACCESSORIES
    • 6.4.1. ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES

7. INFERTILITY TREATMENT MARKET, BY PROCEDURE

  • 7.1. INTRODUCTION
  • 7.2. ASSISTED REPRODUCTIVE TECHNOLOGY
    • 7.2.1. IN VITRO FERTILIZATION
      • 7.2.1.1. Intracytoplasmic morphologically selected sperm injection
        • 7.2.1.1.1. IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure
      • 7.2.1.2. Gamete donation
        • 7.2.1.2.1. Increase in the number of women registering as egg donors is a key factor aiding market growth
    • 7.2.2. INTRACYTOPLASMIC SPERM INJECTION
      • 7.2.2.1. ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures
    • 7.2.3. SURROGACY
      • 7.2.3.1. High success rates guaranteed and achieved with the help of surrogacy are driving market growth
  • 7.3. ARTIFICIAL INSEMINATION
    • 7.3.1. INTRAUTERINE INSEMINATION
      • 7.3.1.1. Limited risk of complications during pregnancy and high success rates driving market demand for IUI procedures
    • 7.3.2. INTRACERVICAL INSEMINATION
      • 7.3.2.1. Low cost of procedure as compared to other AI procedures leading to increased adoption
    • 7.3.3. INTRATUBAL INSEMINATION
      • 7.3.3.1. Better chances of successful pregnancies using ITI to drive the demand for this procedure
  • 7.4. FERTILITY SURGERY
    • 7.4.1. LAPAROSCOPY
      • 7.4.1.1. Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility
    • 7.4.2. HYSTEROSCOPY
      • 7.4.2.1. Growing demand for minimally invasive procedures driving the adoption of hysteroscopy infertility treatment surgeries globally
    • 7.4.3. MYOMECTOMY
      • 7.4.3.1. Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery
    • 7.4.4. LAPAROTOMY
      • 7.4.4.1. Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system
    • 7.4.5. TUBAL LIGATION REVERSAL
      • 7.4.5.1. Tubal ligation reversal is performed only in women who still have a large portion of healthy fallopian tube remaining
    • 7.4.6. VARICOCELECTOMY
      • 7.4.6.1. Adoption of varicocelectomy is high among patients and results in a high chance of improved fertility with reduced complications
    • 7.4.7. MICROSURGICAL RECONSTRUCTION
      • 7.4.7.1. Vasovasostomy
        • 7.4.7.1.1. Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men
      • 7.4.7.2. Vasoepididymostomy
        • 7.4.7.2.1. Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI
  • 7.5. OTHER INFERTILITY TREATMENT PROCEDURES

8. INFERTILITY TREATMENT MARKET, BY PATIENT TYPE

  • 8.1. INTRODUCTION
  • 8.2. FEMALE INFERTILITY TREATMENT
    • 8.2.1. INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET
  • 8.3. MALE INFERTILITY TREATMENT
    • 8.3.1. GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO PROVIDE POTENTIAL GROWTH OPPORTUNITIES

9. INFERTILITY TREATMENT MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. FERTILITY CENTERS
    • 9.2.1. GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE DRIVING GROWTH OF THIS SEGMENT
  • 9.3. HOSPITALS AND SURGICAL CLINICS
    • 9.3.1. INITIATIVES UNDERTAKEN BY GOVERNMENTS TO INCREASE THE NUMBER OF HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES CONTRIBUTING TO MARKET GROWTH
  • 9.4. RESEARCH INSTITUTES
    • 9.4.1. GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS DRIVING MARKET GROWTH IN RESEARCH INSTITUTES
  • 9.5. CRYOBANKS
    • 9.5.1. INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT DRIVING THE DEMAND FOR CRYOBANKS

10. INFERTILITY TREATMENT MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. US to dominate the infertility treatment market in North America
    • 10.2.2. CANADA
      • 10.2.2.1. Government initiatives and legislations for same-sex marriages to drive market growth in Canada
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Favorable funding scenario for IVF treatments in Germany to drive the growth of the infertility treatment market in the country
    • 10.3.2. UK
      • 10.3.2.1. Increase in the number of IVF cycles in the UK contributing to market growth
    • 10.3.3. FRANCE
      • 10.3.3.1. The ART segment dominated the infertility treatment procedures market in France
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
      • 10.4.1.1. Growing awareness has served to boost the adoption of IVF procedures in Japan
    • 10.4.2. CHINA
      • 10.4.2.1. Declining newborn population and birth rate in China to drive the demand for infertility treatment procedures in the country
    • 10.4.3. INDIA
      • 10.4.3.1. Rising fertility medical tourism offering high-growth opportunities for the infertility treatment market in India
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD
    • 10.5.1. LATIN AMERICA
      • 10.5.1.1. Latin America to account for the largest share of the Rest of the World infertility treatment market
    • 10.5.2. MIDDLE EAST & AFRICA
      • 10.5.2.1. Rising incidence of male-factor infertility to drive market growth during the forecast period

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. INFERTILITY TREATMENT: MARKET SHARE ANALYSIS, 2017
  • 11.3. COMPETITIVE SCENARIO

12. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 12.1. COOK GROUP INCORPORATED
  • 12.2. ESCO MICRO PTE. LTD.
  • 12.3. GENEA LIMITED
  • 12.4. HAMILTON THRONE, LTD.
  • 12.5. IHMEDICAL A/S
  • 12.6. IRVINE SCIENTIFIC(A MEMBER OF JX HOLDINGS GROUP)
  • 12.7. IVFTECH APS
  • 12.8. KITAZATO CORPORATION
  • 12.9. MEDGYN PRODUCTS, INC.
  • 12.10. ROCKET MEDICAL PLC
  • 12.11. SOMATEX MEDICAL TECHNOLOGIES GMBH
  • 12.12. THE BAKER COMPANY, INC.
  • 12.13. THE COOPER COMPANIES, INC.
  • 12.14. THERMO FISHER SCIENTIFIC
  • 12.15. VITROLIFE AB
  • 12.16. ZEISS GROUP

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS
Back to Top